AstraZeneca

In News

AstraZeneca CEO Pascal Soriot: 'The pharmaceutical industry in Europe will be reduced to a shadow of itself within 15 years' - Le Monde.fr

Le Monde.fr - Dec 18, 2025

AstraZeneca, Daiichi's breast cancer drug gets FDA nod as first-line treatment - Reuters

Reuters - Dec 15, 2025

AstraZeneca Can't Block Colo. Law Over Drug Discount Rules - Law360

Law360 - Dec 18, 2025

Is It Too Late To Consider AstraZeneca After Its Strong 2025 Share Price Rally? - Yahoo Finance

Yahoo Finance - Dec 19, 2025

BMS Forges $1B+ Antibody Alliance With Chinese Firm Harbour - BioSpace

BioSpace - Dec 17, 2025

AZ, Daiichi score with FDA nod for Enhertu combo in 1st-line breast cancer - Fierce Pharma

Fierce Pharma - Dec 15, 2025

AstraZeneca’s AZD5004 Obesity Trial Edges Forward, Raising New Questions for Investors - TipRanks

TipRanks - Dec 18, 2025

Cancer immunotherapy royalty deal brings biotech up to $90M in funding - Stock Titan

Stock Titan - Dec 17, 2025

Enhertu combo wins FDA approval for first-line use in HER2+ metastatic breast cancer - Endpoints News

Endpoints News - Dec 15, 2025

Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million - Yahoo Finance

Yahoo Finance - Dec 17, 2025

Is It Too Late To Consider AstraZeneca After Its Strong 2025 Share Price Rally? - Yahoo Finance UK

Yahoo Finance UK - Dec 19, 2025

AstraZeneca Fails to Block Colorado Contract Pharmacy Regulation - Bloomberg Law News

Bloomberg Law News - Dec 18, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment